Abstract
Objective: Neuraxial administration of steroids have been used in clinical practice for more than 50 years and have a well defined place in the treatment of radicular low back pain. However, steroids have widespread effects on almost all body systems, such as suppression of the pituitary-adrenal axis with consecutive weight gain and osteoporosis. Methods: We prospectively evaluated the effect of three consecutive epidural steroid injections with 40 mg. methylprednisolone acetate once monthly for 3 months on weight gain. The study population included 108 patients, who attended the pain clinic for chronic low back pain. Completed data were available for 100 patients. Results: We found no significant change in weight after administration of a series of three-epidural steroid injections. Discussion: It appears that neuraxial steroids administration doesnt induce weight gain.
Keywords: Epidural steroid injection, weight gain, low back pain
Current Drug Safety
Title: Epidural Steroid Injections Do Not Induce Weight Gain
Volume: 2 Issue: 2
Author(s): Silviu Brill, Andrei Swartz and Gherta Brill
Affiliation:
Keywords: Epidural steroid injection, weight gain, low back pain
Abstract: Objective: Neuraxial administration of steroids have been used in clinical practice for more than 50 years and have a well defined place in the treatment of radicular low back pain. However, steroids have widespread effects on almost all body systems, such as suppression of the pituitary-adrenal axis with consecutive weight gain and osteoporosis. Methods: We prospectively evaluated the effect of three consecutive epidural steroid injections with 40 mg. methylprednisolone acetate once monthly for 3 months on weight gain. The study population included 108 patients, who attended the pain clinic for chronic low back pain. Completed data were available for 100 patients. Results: We found no significant change in weight after administration of a series of three-epidural steroid injections. Discussion: It appears that neuraxial steroids administration doesnt induce weight gain.
Export Options
About this article
Cite this article as:
Brill Silviu, Swartz Andrei and Brill Gherta, Epidural Steroid Injections Do Not Induce Weight Gain, Current Drug Safety 2007; 2 (2) . https://dx.doi.org/10.2174/157488607780598322
DOI https://dx.doi.org/10.2174/157488607780598322 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vascular C-Reactive Protein in the Pathogenesis of Coronary Artery Disease:Role of Vascular Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders-Drug Targets Molecular Mapping and Docking Interactions for Selective Anti-Fertility Potency of Estrogen Analogs
Letters in Drug Design & Discovery Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Current Hypertension Reviews Bariatric Surgery - Effects on Obesity and Related co-Morbidities
Current Diabetes Reviews Synthesis, Molecular Modeling of Novel Substituted Pyridazinones and their Vasorelaxant Activities
Medicinal Chemistry Editorial [Herbal Remedies in Pulmonary Medicine: A Word of Caution]
Current Respiratory Medicine Reviews Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450
Current Drug Metabolism Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets Interactions between Novel Terpenes and Main Components of Rat and Human Skin: Mechanistic View for Transdermal Delivery of Propranolol Hydrochloride
Current Drug Delivery Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)]
Current Topics in Medicinal Chemistry Cardiovascular and Renal Complications of Type 2 Diabetes in Obesity:Role of Sympathetic Nerve Activity and Insulin Resistance
Current Diabetes Reviews Exploring Structure-based Drug Design for the Development of Multitarget Antihypertensives
Letters in Drug Design & Discovery Biological Characteristics and Role of Histamine in Case of Allergic Rhinitis
Medicinal Chemistry Reviews - Online (Discontinued) Endocannabinoid Metabolic Pathways and Enzymes
Current Drug Targets - CNS & Neurological Disorders Dark Chocolate and Blood Pressure: A Novel Study from Jordan
Current Drug Delivery Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ)-Modulating Activity for the Treatment of Cardiometabolic Disorders
Current Molecular Medicine Heart Failure in North America
Current Cardiology Reviews Erectile Dysfunction and Coronary Artery Disease in Patients with Diabetes
Current Diabetes Reviews Dissecting abdominal aortic aneurysm in Angiotensin II-infused mice: the importance of imaging
Current Pharmaceutical Design